Molecular Partners Company Profile

Aggregated data from the web about Molecular Partners

Company Name	Molecular Partners
Website	https://www.molecularpartners.com
Snippet	We are deeply motivated to deliver unique therapies to people with cancer and other serious diseases. Hear what drives us to go the extra mile. The Molecular Partners team is unique because we share a common vision and combine our diverse experiences and skill sets to achieve our goals. Andreas
Type	Public
Founded	2004
Revenue	29.1 million Swiss francs (CHF) (FY 2015)[1]
Website	www.molecularpartners.com
Industry	Biotechnology
Traded as	SIX: MOLN
Key people	William M. Burns, Chairman of the BoardDr. Patrick Amstutz, Chief Executive OfficerDr. Michael Stumpp, Chief Operating OfficerAndreas Emmenegger, Chief Financial OfficerDr. Nicolas Leupin, Chief Medical Officer
Headquarters	Schlieren, Zürich, Switzerland
Total assets	CHF 194.0 million (Dec 31, 2015)[1]
Total equity	CHF 151.8 million (Dec 31, 2015) [1]
Operating income	CHF -2.2 million (FY 2015)[1]
Number of employees	89 FTE (Dec. 31, 2015) [1]

Molecular Partners is part of the Switzerland company list

Molecular Partners is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.